The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTekCapital Regulatory News (TEK)

Share Price Information for TekCapital (TEK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.15
Bid: 7.80
Ask: 8.50
Change: 0.00 (0.00%)
Spread: 0.70 (8.974%)
Open: 8.15
High: 8.15
Low: 8.15
Prev. Close: 8.15
TEK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Salarius Secures & Delivers Follow-on Order

13 Jun 2019 07:00

RNS Number : 0352C
Tekcapital plc
13 June 2019
 

 

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR"). With the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

 

13 June 2019

Tekcapital Plc

("Tekcapital", the "Company" or "the Group")

Portfolio Company Update:

 

Salarius Secures & Delivers Follow-on Order for MicroSalt® and

Completes Test Production of SaltMeTM Potato Chip Snacks

 

Tekcapital Plc (AIM: TEK), the UK intellectual property (IP) investment group focused on creating marketplace value from investing in university technology, is very pleased to announce that its portfolio company Salarius ltd. has secured & delivered a follow-on order for MicroSalt® for a U.S. snack food company and completed test production of its SaltMeTM potato chip snacks.

 

MicroSalt® is a proprietary salt made with micron-size salt particles that dissolve in the mouth significantly faster than regular salt, delivering an increased sensation of saltiness with much less salt, and as a result approximately 50% less sodium.

 

Salarius plans to introduce the SaltMeTM line of full-flavor, low-sodium chips later this year in four varieties: original, barbecue, sour cream & onion and cheddar & sour cream. Panel testing amongst salty snack buyers resulted in a weighted purchase intent of 27.75%, which is significantly higher than average new product initiatives.

 

High blood pressure is a key risk factor for developing heart disease. Consistent with this, the National Academies of Sciences, Engineering, and Medicine has recently recommended reduced sodium consumption guidelines1. MicroSalt® and SaltMeTM snacks can help food companies and consumers meet these new guidelines.

 

Market Information

The low sodium ingredient market is estimated to reach US$1.76 billion by 2025 with a CAGR 11.7%2. The highly competitive global savory snacks market is expected to reach US$108 billion by 20213.

 

Victor Hugo Manzanilla, CEO of Salarius said,

"We are very glad to announce the follow-on order for MicroSalt® and the successful test production of our new SaltMeTM chips. Consumers are aware of the need to eat healthier and select better-for-you options when available. MicroSalt® and SaltMeTM snacks will help consumers reduce sodium consumption whilst providing the great salty taste they enjoy. MicroSalt® is non-GMO and all natural. In addition, the small size of MicroSalt® provides better adhesion to the food surface, reducing the amount of salt that falls off products during transport and display, reducing waste and helping to ensure a consistent flavor profile."

 

Dr Clifford Gross, Executive Chairman at Tekcapital, commented: "We are delighted with Salarius' continued progress as a result of the terrific work of Victor Manzanilla their CEO, and his capable team. MicroSalt® has the potential to empower companies and consumers worldwide to enjoy full-flavour snacks with reduced sodium."

 

Tekcapital owns 97.5% of the share capital of Salarius ltd.

 

About Salarius ltd

Salarius, is the developer and manufacturer of a proprietary low sodium salt called MicroSalt®. Salarius is passionate about improving lives with healthier food and is taking the lead in the industry by providing the best low-sodium salt solution, based on the mechanical transformation of the salt particle itself. This solution is the only one that delivers real salt flavor, because it is salt. The technology produces salt crystals that are approximately one hundred times smaller than typical table salt, delivering a powerful saltiness as the micro-grains dissolve in the mouth, with approximately 50% less sodium consumption. To learn more please visit https://salarius.co/.

 

About Tekcapital plc

Tekcapital creates value from investing in new, university-developed intellectual properties and provides a range of IP investment services to make it easy for organisations to commercialise university-developed technology. Tekcapital is quoted on the AIM market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in Oxford, in the UK. For more information, please visit www.tekcapital.com

LEI: 213800GOJTOV19FIFZ85

For further information, please contact:

 

Tekcapital Plc 

 

Via Yellow Jersey PR 

Clifford M. Gross, Ph.D. 

 

 

 

 

 

finnCap Ltd (Nominated Adviser and Joint Broker)

 

+44 (0) 20 7220 0500 

Geoff Nash/ Max Bullen-Smith (Corporate Finance)

 

 

Camille Gochez (ECM) 

 

 

Novum Securities Limited (Joint Broker) 

 

+44 (0) 20 7399 9427

Colin Rowbury (Corporate Broking) 

 

 

 

 

 

Yellow Jersey Limited

 

+44 (0) 20 3004 9512

Tim Thompson / Annabel Atkins 

 

tekcapital@yellowjerseypr.com 

 

References

 

1 http://www8.nationalacademies.org/onpinews/newsitem.aspx?RecordID=25353

2 https://www.futuremarketinsights.com/reports/sodium-reduction-ingredient-market

3 https://zmrindustryjournal.us/8402/savory-snacks-market-size-share-expanding-across-the-globe-by-2016-2024/

 

This press release is for informational purposes only. The information herein does not constitute investment advice nor an offer to invest and may contain statements related to our future business and financial performance and future events or developments involving Salarius that may constitute forward-looking statements. These statements may be identified by words such as "expect," "look forward to," "anticipate" "intend," "plan," "believe," "seek," "estimate," "will," "project" or words of similar meaning. We may also make forward-looking statements in other reports, in presentations, in material delivered to customers, stakeholders and in press releases. In addition, our representatives may from time to time make oral forward-looking statements. Such statements may be based on the current expectations and certain assumptions of Salarius' management. Please note that these are subject to a number of risks, uncertainties and factors, including, but not limited to those described in various disclosures. Should one or more of these risks or uncertainties materialize, or should underlying expectations not occur or assumptions prove incorrect, actual results, performance or achievements of Salarius may vary materially from those described explicitly or implicitly in the relevant forward-looking statement. Salarius neither intends, nor assumes any obligation, to update or revise these forward-looking statements in light of developments which differ from those anticipated.

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCDMGMVLZDGLZM
Date   Source Headline
2nd Aug 20194:15 pmRNSHolding(s) in Company
1st Aug 201911:35 amRNSHolding(s) in Company
1st Aug 201911:34 amRNSHolding(s) in Company
25th Jul 20197:00 amRNSInvestor Conference Call
22nd Jul 20197:00 amRNSExpansion of Tekcapital services in Mexico
16th Jul 20197:00 amRNSNotice of Investor Conference Call
11th Jul 20197:00 amRNSPlacing to raise £0.75 million
27th Jun 20197:00 amRNSGuident Acquires Additional IP
26th Jun 20197:00 amRNSBelluscura likely to receive FDA clearance in 2019
25th Jun 20197:00 amRNSGuident Acquires Additional IP
24th Jun 20197:00 amRNSSalarius Secures New Order for MicroSalt®
13th Jun 20197:00 amRNSSalarius Secures & Delivers Follow-on Order
14th May 20197:00 amRNSLucyd Launches Loud 2.0 Eyewear Line
3rd May 20197:00 amRNSFlorida Legislature Approves Autonomous Vehicles
29th Apr 20197:00 amRNSGuident Files Additional Patent
24th Apr 20197:00 amRNSPortfolio company, Belluscura plc, raises £500,730
23rd Apr 201911:05 amRNSSecond Price Monitoring Extn
23rd Apr 201911:00 amRNSPrice Monitoring Extension
23rd Apr 20197:00 amRNSSalarius secures first commercial order
5th Apr 20193:12 pmRNSResult of AGM
2nd Apr 20197:00 amRNSStrategic Alliance Agreement with Emprende UP
1st Apr 20197:00 amRNSPortfolio Company Update
25th Mar 20197:00 amRNSAttendance at UK Investor Show
25th Mar 20197:00 amRNSPortfolio Company Update
14th Mar 20197:00 amRNSInvestor conference call
14th Mar 20197:00 amRNSPosting of Annual Report and Notice of AGM
1st Mar 20195:26 pmRNSHolding(s) in Company
26th Feb 20197:00 amRNSUpdate of Research Coverage
26th Feb 20197:00 amRNSNotice of Investor Conference Call
25th Feb 20197:00 amRNSFull Year 2018 Preliminary Results
21st Feb 20197:00 amRNSLucyd Provides Market Update
21st Feb 20197:00 amRNSNotice of Preliminary Results Announcement
19th Feb 20198:52 amRNSBelluscura Files Additional Patent
15th Feb 20193:26 pmRNSHolding(s) in Company
30th Jan 20199:23 amRNSHolding(s) in Company
14th Jan 20197:00 amRNSGuident Ltd Appoints Director
17th Dec 20184:36 pmRNSHolding(s) in Company
12th Dec 20187:00 amRNSUniversity IP webinar
6th Dec 20187:00 amRNSGuident Ltd Appoints Director
3rd Dec 20187:00 amRNSLucyd Signs R Sherman as Chief Brand Officer
26th Nov 20187:00 amRNSMello London
14th Nov 20187:00 amRNSLucyd Launches Affiliate and Reseller Program
8th Nov 201811:34 amRNSHolding(s) in Company
19th Oct 20181:52 pmRNSHolding(s) in Company
18th Oct 20185:25 pmRNSHolding(s) in Company
16th Oct 20185:02 pmRNSHolding(s) in Company
15th Oct 20187:00 amRNSPortfolio Company Update
9th Oct 20187:00 amRNSExecutive Appointment
5th Oct 20187:00 amRNSScience Advisor Appointment
3rd Oct 20187:00 amRNSPublication of Research Note

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.